Back to News
Mergers & Acquisitions

Drinks With The Deal: Mintz's Matthew Simpson

Published: October 1st, 2021
The Mintz partner discusses his transition from peace negotiator to M&A lawyer, why he enjoys the middle market, what he's learned from advising reps and warranties insurers and how he finds serenity on sailboats in the latest edition of Drinks With The Deal.

Matthew Simpson came to an unexpected realization after advising the Darfur delegation in peace negotiations with the government of Sudan, he said on this week’s Drinks With The Deal podcast. “My job was to coordinate and be a strategic adviser to the Darfuri leadership, and I realized I really enjoyed dealmaking and liked that quarterback role.”

Simpson had worked as an international trade lawyer before he shifted to working on the Darfur peace talks, but he concluded that he wanted to be a deal lawyer. After a stint working on large private equity deals for Canadian clients at Torys LLP in New York, he moved to Mintz, Levin, Cohn, Ferris, Glovsky and Popeo PC in Washington. Simpson’s assistant at Torys had worked for Susan Bersan, who manages Mintz’s Washington office, and told him he should meet Berson, who “understood my nonlinear career path,” Simpson said.

He joined Mintz in 2014 and is now a partner at the firm, where he advises a range of clients with a focus on middle-market private equity, which he finds “a completely different beast because you’re dealing with real people” who are selling businesses that they or their families have often built. Simpson also advises providers of representations and warranties insurance, which gives him a different perspective on middle-market private equity.

“Every deal I’ve seen can get done,” he said, though not every one has. “It just depends on your risk tolerances and how you allocate them. My job is to help people think through those risks.”

Here’s the podcast:

More podcasts from The Deal are available on iTunesSpotify and on

More From Mergers & Acquisitions

Mergers & Acquisitions

Drinks With The Deal: Krishna Veeraraghavan of Paul Weiss

By David Marcus
Published: October 14th, 2021
M&A lawyer Krishna Veeraraghavan talked about healthcare dealmaking and the risks of excessive antitrust regulation of combinations between biotech and pharma companies in the Drinks With The Deal podcast.
Mergers & Acquisitions

OpEd: ESG in Due Diligence Is Not Just Another Box to Check

By Deal Contributors
Published: October 5th, 2021
With ESG now a day-to-day focus for management and directors across industries, companies would be well-served to undertake a thoughtful assessment of ESG risks when evaluating potential targets in M&A activities.

CorpGov: Barshay Says Lina Khan Can't Sue Everybody

By Tom Terrarosa
Published: October 1st, 2021
The powerhouse corporate attorney handed out some advice to companies, ESG investors and the broader investment community at The Deal's Corporate Governance 2021 conference.